fishing images

fishing images The high-speed overhead doors people deserveFalcons drafting Penix no longer a head-scratcher with rookie QB shining in place of benched Cousins

Herbert tosses 3 TD passes and Chargers secure a playoff spot with a 40-7 rout of Patriots FOXBOROUGH, Mass. (AP) — Justin Herbert threw three touchdown passes and the Los Angeles Chargers clinched their second playoff appearance in three seasons with a 40-7 victory over the New England Patriots. The win also secured the fourth postseason appearance in Jim Harbaugh’s five seasons as an NFL coach, adding to the three he made during his stint with tAshe San Francisco 49ers. Herbert finished 26 of 38 for 281 yards to become the third player in NFL history with at least 3,000 passing yards and 20 touchdown passes in each of his first five seasons. The Patriots have lost six straight games, their second such losing streak of the season. They are now 2-14 the last two seasons at home. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

SAN DIEGO, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), have until Friday, December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action lawsuit. Captioned Patel v. Edwards Lifesciences Corporation , No. 24-cv-02221 (C.D. Cal.), the Edwards Lifesciences class action lawsuit charges Edwards Lifesciences and certain of Edwards Lifesciences’ top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Edwards Lifesciences class action lawsuit, please provide your information here: https://www.rgrdlaw.com/cases-edwards-lifesciences-corporation-class-action-lawsuit-ew.html You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com . CASE ALLEGATIONS : Edwards Lifesciences provides products and technologies for structural heart disease and critical care monitoring. One of Edward Lifesciences’ core products is Transcatheter Aortic Valve Replacement (“TAVR”). The Edwards Lifesciences class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Edwards Lifesciences’ projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations; (ii) TAVR’s growth was at risk of decelerating; (iii) Edwards Lifesciences’ optimistic reports of TAVR’s growth and anticipated ramp in second quarter 2024 and further ramp throughout fiscal year 2024 fell short of reality as defendants’ “patient activation activities” failed to reach the perceived low-treatment-rate population TAVR’s growth relied upon obtaining; and (iv) defendants relied far too heavily or otherwise overstated hospital desire to continue to utilize Edwards Lifesciences’ TAVR procedures over newer, innovative structural heart therapies. The Edwards Lifesciences class action lawsuit further alleges that on July 24, 2024, Edwards Lifesciences disclosed second quarter 2024 TAVR results below expectations and lowered fiscal year 2024 projections for TAVR. On this news, the price of Edwards Lifesciences stock fell more than 31%, according to the complaint. THE LEAD PLAINTIFF PROCESS : The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Edwards Lifesciences securities during the Class Period to seek appointment as lead plaintiff in the Edwards Lifesciences class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Edwards Lifesciences class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Edwards Lifesciences class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Edwards Lifesciences class action lawsuit. ABOUT ROBBINS GELLER : Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud cases. Our Firm has been #1 in the ISS Securities Class Action Services rankings for six out of the last ten years for securing the most monetary relief for investors. We recovered $6.6 billion for investors in securities-related class action cases – over $2.2 billion more than any other law firm in the last four years. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: https://www.rgrdlaw.com/services-litigation-securities-fraud.html Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Contact: Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 info@rgrdlaw.comBeyond Bank and Cognizant join forces to lead the future of customer-owned banking

ST. JOHNS, Mich. , Dec. 11, 2024 /PRNewswire/ -- AgroLiquid , a leader in high-efficiency crop liquid fertilizer solutions, today announced the acquisition of Monty's Plant Food Company , a Louisville -based specialist in soil health and plant nutrition technology. The acquisition, effective Jan. 1, 2025 , brings together two family-founded businesses that excel in agricultural innovation and share a commitment to farmer success. "This strategic combination allows us to bring crop nutrition technologies to growers that wouldnʼt otherwise be available to them," said Nick Bancroft , CEO of AgroLiquid. "While both companies share the same goals in advancing agricultural innovation, our different approaches to achieving them will create new opportunities to optimize nutrient efficiency and productivity for growers." The acquisition unites AgroLiquidʼs expertise in liquid fertilizer solutions with Monty's specialized knowledge in soil health and humic technology . Both companies will maintain their distinct brands and continue operating independently through the 2025 growing season. "Joining forces with AgroLiquid marks an exciting new chapter for Monty's Plant Food," said Jeff Sangalli , CEO of Montyʼs Plant Food Company. "Our shared farmer-first philosophy and commitment to innovation made this a natural fit. By combining our complementary strengths, we're positioned to deliver even greater value to the agricultural industry." The integration will focus on leveraging operational capabilities, including manufacturing, warehousing and storage infrastructure. Following the acquisition, Monty's Plant Food will continue operating under its current name as a privately owned company, with Jeff Sangalli continuing to lead the business. About AgroLiquid AgroLiquid , headquartered in St. Johns, Mich. , manufactures and distributes high-efficiency liquid fertilizer formulated to protect nutrients from loss to the environment. AgroLiquid's products work with, instead of against, the biology of the soil, which makes them more usable by the crop. Continuous research and product improvement, coupled with an ethical business model, keep AgroLiquid focused on its mission: "To Prosper the Farmer." About Monty's Plant Food Company Monty's Plant Food Company , headquartered in Louisville, Ky. , manufactures plant and soil enhancement products for agriculture, lawn and garden, turf, hemp and wildlife markets. Founded in 1997, Monty's combines proprietary humic technology with traditional nutrients to develop innovative, environmentally responsible solutions that maximize crop yields. For 27 years, the company has served as a trusted advisor in soil health and plant nutrition, delivering proven solutions to agricultural communities worldwide. View original content to download multimedia: https://www.prnewswire.com/news-releases/agroliquid-to-acquire-montys-plant-food-company-expanding-innovation-in-agricultural-crop-nutrition-302329455.html SOURCE AgroLiquid

Franklin Resources Inc. Has $1.68 Million Stock Position in G-III Apparel Group, Ltd. (NASDAQ:GIII)

Pheu Thai, Bhumjaithai parties reaffirm coalition unity

De Bruyne's return helps Manchester City break winless run, but problems persistColts QB Anthony Richardson ruled out for Sunday’s game against the Giants